Literature DB >> 21546381

Neuron-specific proteotoxicity of mutant ataxin-3 in C. elegans: rescue by the DAF-16 and HSF-1 pathways.

Andreia Teixeira-Castro1, Michael Ailion, Ana Jalles, Heather R Brignull, João L Vilaça, Nuno Dias, Pedro Rodrigues, João F Oliveira, Andreia Neves-Carvalho, Richard I Morimoto, Patrícia Maciel.   

Abstract

The risk of developing neurodegenerative diseases increases with age. Although many of the molecular pathways regulating proteotoxic stress and longevity are well characterized, their contribution to disease susceptibility remains unclear. In this study, we describe a new Caenorhabditis elegans model of Machado-Joseph disease pathogenesis. Pan-neuronal expression of mutant ATXN3 leads to a polyQ-length dependent, neuron subtype-specific aggregation and neuronal dysfunction. Analysis of different neurons revealed a pattern of dorsal nerve cord and sensory neuron susceptibility to mutant ataxin-3 that was distinct from the aggregation and toxicity profiles of polyQ-alone proteins. This reveals that the sequences flanking the polyQ-stretch in ATXN3 have a dominant influence on cell-intrinsic neuronal factors that modulate polyQ-mediated pathogenesis. Aging influences the ATXN3 phenotypes which can be suppressed by the downregulation of the insulin/insulin growth factor-1-like signaling pathway and activation of heat shock factor-1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21546381      PMCID: PMC3131043          DOI: 10.1093/hmg/ddr203

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  74 in total

1.  Calpain inhibition is sufficient to suppress aggregation of polyglutamine-expanded ataxin-3.

Authors:  Annette Haacke; F Ulrich Hartl; Peter Breuer
Journal:  J Biol Chem       Date:  2007-05-08       Impact factor: 5.157

2.  Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3.

Authors:  B O Evert; J Schelhaas; H Fleischer; R A I de Vos; E R Brunt; W Stenzel; T Klockgether; U Wüllner
Journal:  Clin Neuropathol       Date:  2006 Nov-Dec       Impact factor: 1.368

3.  Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3.

Authors:  Ana-João Rodrigues; Giovanni Coppola; Cláudia Santos; Maria do Carmo Costa; Michael Ailion; Jorge Sequeiros; Daniel H Geschwind; Patrícia Maciel
Journal:  FASEB J       Date:  2007-01-18       Impact factor: 5.191

4.  Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells.

Authors:  Susana M Garcia; M Olivia Casanueva; M Catarina Silva; Margarida D Amaral; Richard I Morimoto
Journal:  Genes Dev       Date:  2007-11-15       Impact factor: 11.361

Review 5.  Changes in the structural complexity of the aged brain.

Authors:  Dara L Dickstein; Doron Kabaso; Anne B Rocher; Jennifer I Luebke; Susan L Wearne; Patrick R Hof
Journal:  Aging Cell       Date:  2007-04-26       Impact factor: 9.304

6.  Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.

Authors:  Tiago Fleming Outeiro; Eirene Kontopoulos; Stephen M Altmann; Irina Kufareva; Katherine E Strathearn; Allison M Amore; Catherine B Volk; Michele M Maxwell; Jean-Christophe Rochet; Pamela J McLean; Anne B Young; Ruben Abagyan; Mel B Feany; Bradley T Hyman; Aleksey G Kazantsev
Journal:  Science       Date:  2007-06-21       Impact factor: 47.728

7.  Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence.

Authors:  Ulrike Bichelmeier; Thorsten Schmidt; Jeannette Hübener; Jana Boy; Lukas Rüttiger; Karina Häbig; Sven Poths; Michael Bonin; Marlies Knipper; Werner J Schmidt; Johannes Wilbertz; Hartwig Wolburg; Franco Laccone; Olaf Riess
Journal:  J Neurosci       Date:  2007-07-11       Impact factor: 6.167

8.  A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice.

Authors:  Veronica F Colomer Gould; Daniel Goti; Donna Pearce; Guillermo A Gonzalez; Hong Gao; Mario Bermudez de Leon; Nancy A Jenkins; Neal G Copeland; Christopher A Ross; Dale R Brown
Journal:  Neurobiol Dis       Date:  2007-06-13       Impact factor: 5.996

9.  NEDD8: a new ataxin-3 interactor.

Authors:  Anabela Ferro; Ana Luísa Carvalho; Andreia Teixeira-Castro; Carla Almeida; Ricardo J Tomé; Luísa Cortes; Ana-João Rodrigues; Elsa Logarinho; Jorge Sequeiros; Sandra Macedo-Ribeiro; Patrícia Maciel
Journal:  Biochim Biophys Acta       Date:  2007-08-24

10.  Identification of potential therapeutic drugs for huntington's disease using Caenorhabditis elegans.

Authors:  Cindy Voisine; Hemant Varma; Nicola Walker; Emily A Bates; Brent R Stockwell; Anne C Hart
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

View more
  47 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 2.  Heat shock transcription factor 1 as a therapeutic target in neurodegenerative diseases.

Authors:  Daniel W Neef; Alex M Jaeger; Dennis J Thiele
Journal:  Nat Rev Drug Discov       Date:  2011-12-01       Impact factor: 84.694

Review 3.  Models and mechanisms of repeat expansion disorders: a worm's eye view.

Authors:  Paige Rudich; Todd Lamitina
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool.

Authors:  Márcio S Baptista; Carlos B Duarte; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

5.  Alzheimer's disease-causing proline substitutions lead to presenilin 1 aggregation and malfunction.

Authors:  Tziona Ben-Gedalya; Lorna Moll; Michal Bejerano-Sagie; Samuel Frere; Wayne A Cabral; Dinorah Friedmann-Morvinski; Inna Slutsky; Tal Burstyn-Cohen; Joan C Marini; Ehud Cohen
Journal:  EMBO J       Date:  2015-10-05       Impact factor: 11.598

6.  Loss of glutathione redox homeostasis impairs proteostasis by inhibiting autophagy-dependent protein degradation.

Authors:  David Guerrero-Gómez; José Antonio Mora-Lorca; Beatriz Sáenz-Narciso; Francisco José Naranjo-Galindo; Fernando Muñoz-Lobato; Cristina Parrado-Fernández; Julen Goikolea; Ángel Cedazo-Minguez; Christopher D Link; Christian Neri; María Dolores Sequedo; Rafael P Vázquez-Manrique; Elena Fernández-Suárez; Veit Goder; Roser Pané; Elisa Cabiscol; Peter Askjaer; Juan Cabello; Antonio Miranda-Vizuete
Journal:  Cell Death Differ       Date:  2019-02-15       Impact factor: 15.828

7.  Serotonergic signalling suppresses ataxin 3 aggregation and neurotoxicity in animal models of Machado-Joseph disease.

Authors:  Andreia Teixeira-Castro; Ana Jalles; Sofia Esteves; Soosung Kang; Liliana da Silva Santos; Anabela Silva-Fernandes; Mário F Neto; Renée M Brielmann; Carlos Bessa; Sara Duarte-Silva; Adriana Miranda; Stéphanie Oliveira; Andreia Neves-Carvalho; João Bessa; Teresa Summavielle; Richard B Silverman; Pedro Oliveira; Richard I Morimoto; Patrícia Maciel
Journal:  Brain       Date:  2015-09-15       Impact factor: 13.501

8.  Unbiased screen identifies aripiprazole as a modulator of abundance of the polyglutamine disease protein, ataxin-3.

Authors:  Maria do Carmo Costa; Naila S Ashraf; Svetlana Fischer; Yemen Yang; Emily Schapka; Gnanada Joshi; Thomas J McQuade; Rahil M Dharia; Mark Dulchavsky; Michelle Ouyang; David Cook; Duxin Sun; Martha J Larsen; Jason E Gestwicki; Sokol V Todi; Magdalena I Ivanova; Henry L Paulson
Journal:  Brain       Date:  2016-11-01       Impact factor: 13.501

Review 9.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

10.  Toward RNAi therapy for the polyglutamine disease Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Katiuska Luna-Cancalon; Svetlana Fischer; Naila S Ashraf; Michelle Ouyang; Rahil M Dharia; Lucas Martin-Fishman; Yemen Yang; Vikram G Shakkottai; Beverly L Davidson; Edgardo Rodríguez-Lebrón; Henry L Paulson
Journal:  Mol Ther       Date:  2013-06-14       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.